Lukas Biomedical Inc. (6814.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$17.60 (+0.00%) as of
Key statistics
- Market cap
- 736.98M
- EPS (TTM)
- -2.20
- Dividend yield
- 0.00%
- 52-week range
- 16.85 – 32.50
- Beta
- 0.06
- Revenue (TTM)
- 170.01M
- Profit margin
- -54.14%
- Volume
- 2.05k
About Lukas Biomedical Inc.
Lukas Biomedical Inc. engages in the wholesale and retail of cosmetics in Taiwan. The company operates through E-Commerce Department, Medical Management Business, Cell Products Department, and Pharmaceutical Market Development Department segments. It also researches and develops immune cell medical technology for regenerative medicine and adjuvant treatment; engages in clinical trials; distributes immune cell therapy culture technology; and leases building equipment. In addition, the company involved in the new immune cell research and development, new product development, clinical trials, and production of cell reagents; and provision of brand management and medical management services. Lukas Biomedical Inc. was founded in 2002 and is based in New Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New Taipei City, Taiwan
- Employees
- 87
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.